Back to User profile » Dr Qunfang Zhou
Papers published by Dr Qunfang Zhou:
Original Research
Survival Benefit of Lenvatinib Plus PD-1 Inhibitor with or Without HAIC in Advanced Hepatocellular Carcinoma Beyond Oligometastasis: a Multicenter Cohort Study
Wang M, Zhou Q, Li H, Liu M, Li R, Wang W, Wang X, Huang J, Duan F
ImmunoTargets and Therapy 2024, 13:447-459
Published Date: 9 September 2024
Original Research
Hepatic Arterial Infusion Chemotherapy Combined Lenvatinib and PD-1 Inhibitor Showed Improved Survival for Infiltrative Hepatocellular Carcinoma: A Multicenter Cohort Study
Li R, Wang X, Li H, Wang M, Wang J, Wang W, Zhou Q
Journal of Hepatocellular Carcinoma 2024, 11:1727-1740
Published Date: 9 September 2024
Original Research
Addition of Immune Checkpoint Inhibitor Showed Better Efficacy for Infiltrative Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy and Lenvatinib: A Multicenter Retrospective Study
Wang W, Li R, Li H, Wang M, Wang J, Wang X, Zhou Q
ImmunoTargets and Therapy 2024, 13:399-412
Published Date: 19 August 2024
